GoodRx, which is a digital prescription price comparison and coupon provider, soared in its first day of trading Wednesday on the Nasdaq.
It priced at $33.
The IPO price was far above the $24 to $28 range set by the underwriters. With 34,615,384 shares sold, the company raised more than $1.1 billion.
GoodRx is backed by private-equity titan Silver Lake as well as Francisco Partners and Spectrum Equity. It has 338 employees.
In the six months ended June 30, GoodRx posted net income of $54.7 million, up from $31.2 million a year earlier. Revenue totaled $256.7 million in revenue, up from $173.2 million a year earlier. Many tech companies going public are nothing close to profitable.
GoodRx had debt $697 million as of June 30.
In its prospectus, the company said its mission was “to help Americans get the healthcare they need at a price they can afford.”
Co-founders and CEOs Doug Hirsch and Trevor Bezdek wrote in the prospectus that “so far, we’ve saved Americans an estimated $20 billion on prescriptions and medical services. We have helped a lot of people save money on their care.”
Latest Videos From TheStreet and Jim Cramer:
- What to Expect from Tesla's Battery Day
- Stocks Rise Without Big Tech's Help
- Microsoft's Biggest Acquisitions
- Why Jim Cramer Says Tesla's Battery Day Is 'Very Bullish'
- Jim Cramer Manages Tech Stocks in His Portfolio
- Jim Cramer Adds Nike to His Action Alerts PLUS Portfolio
- Walmart Targets Zero Carbon Emissions by 2040